These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10457085)
21. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Wetzel CH; Hermann B; Behl C; Pestel E; Rammes G; Zieglgänsberger W; Holsboer F; Rupprecht R Mol Endocrinol; 1998 Sep; 12(9):1441-51. PubMed ID: 9731711 [TBL] [Abstract][Full Text] [Related]
22. Ion permeation properties of a cloned human 5-HT3 receptor transiently expressed in HEK 293 cells. Mochizuki S; Miyake A; Furuichi K Amino Acids; 1999; 17(3):243-55. PubMed ID: 10582123 [TBL] [Abstract][Full Text] [Related]
23. An electrophysiological investigation of the properties of a murine recombinant 5-HT3 receptor stably expressed in HEK 293 cells. Gill CH; Peters JA; Lambert JJ Br J Pharmacol; 1995 Mar; 114(6):1211-21. PubMed ID: 7620711 [TBL] [Abstract][Full Text] [Related]
24. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor. Coultrap SJ; Sun H; Tenner TE; Machu TK J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762 [TBL] [Abstract][Full Text] [Related]
25. Voltage- and time-dependent properties of the recombinant rat vanilloid receptor (rVR1). Gunthorpe MJ; Harries MH; Prinjha RK; Davis JB; Randall A J Physiol; 2000 Jun; 525 Pt 3(Pt 3):747-59. PubMed ID: 10856126 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ligand-gated cation-selective channels by tamoxifen. Allen MC; Newland C; Valverde MA; Hardy SP Eur J Pharmacol; 1998 Aug; 354(2-3):261-9. PubMed ID: 9754928 [TBL] [Abstract][Full Text] [Related]
27. Lamotrigine, an antiepileptic drug, inhibits 5-HT Kim KJ; Jeun SH; Sung KW Korean J Physiol Pharmacol; 2017 Mar; 21(2):169-177. PubMed ID: 28280410 [TBL] [Abstract][Full Text] [Related]
28. Zn2+ inhibition of recombinant GABAA receptors: an allosteric, state-dependent mechanism determined by the gamma-subunit. Gingrich KJ; Burkat PM J Physiol; 1998 Feb; 506 ( Pt 3)(Pt 3):609-25. PubMed ID: 9503325 [TBL] [Abstract][Full Text] [Related]
29. Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols. Rüsch D; Musset B; Wulf H; Schuster A; Raines DE J Pharmacol Exp Ther; 2007 Jun; 321(3):1069-74. PubMed ID: 17360702 [TBL] [Abstract][Full Text] [Related]
30. Ethanol stabilizes the open state of single 5-hydroxytryptamine(3A)(QDA) receptors. Feinberg-Zadek PL; Davies PA J Pharmacol Exp Ther; 2010 Jun; 333(3):896-902. PubMed ID: 20200118 [TBL] [Abstract][Full Text] [Related]
31. Block of the cyclic GMP-gated channel of vertebrate rod and cone photoreceptors by l-cis-diltiazem. Haynes LW J Gen Physiol; 1992 Nov; 100(5):783-801. PubMed ID: 1282145 [TBL] [Abstract][Full Text] [Related]
32. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells. Bartrup JT; Newberry NR J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467 [TBL] [Abstract][Full Text] [Related]
33. Mutations of L293 in transmembrane two of the mouse 5-hydroxytryptamine3A receptor alter gating and alcohol modulatory actions. Hu XQ; Hayrapetyan V; Gadhiya JJ; Rhubottom HE; Lovinger DM; Machu TK Br J Pharmacol; 2006 May; 148(1):88-101. PubMed ID: 16520747 [TBL] [Abstract][Full Text] [Related]
34. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors. Hargreaves AC; Lummis SC; Taylor CW Mol Pharmacol; 1994 Dec; 46(6):1120-8. PubMed ID: 7808432 [TBL] [Abstract][Full Text] [Related]
35. An analysis of philanthotoxin block for recombinant rat GluR6(Q) glutamate receptor channels. Bähring R; Mayer ML J Physiol; 1998 Jun; 509 ( Pt 3)(Pt 3):635-50. PubMed ID: 9596788 [TBL] [Abstract][Full Text] [Related]
36. Modulation of GABA(A) receptor channel gating by pentobarbital. Steinbach JH; Akk G J Physiol; 2001 Dec; 537(Pt 3):715-33. PubMed ID: 11744750 [TBL] [Abstract][Full Text] [Related]
37. Binding characteristics of GYKI-46 903, a non-competitive ligand at 5-HT3 receptors. Vitális B; Sebestyén L; Sike M; Sólyom S; Hársing LG Pharmacol Res; 2001 Mar; 43(3):291-9. PubMed ID: 11401422 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells. Hope AG; Peters JA; Brown AM; Lambert JJ; Blackburn TP Br J Pharmacol; 1996 Jul; 118(5):1237-45. PubMed ID: 8818349 [TBL] [Abstract][Full Text] [Related]
39. Mepacrine-induced inhibition of the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones. Fan P Br J Pharmacol; 1994 Jul; 112(3):745-8. PubMed ID: 7522858 [TBL] [Abstract][Full Text] [Related]
40. Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells. Neijt HC; Plomp JJ; Vijverberg HP J Physiol; 1989 Apr; 411():257-69. PubMed ID: 2482354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]